Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Indrani Bhattacharya

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
European Urology Oncology|January 29, 2025
ProCUSNet: Prostate Cancer Detection on B-mode Transrectal Ultrasound Using Artificial Intelligence for Targeting During Prostate BiopsiesMirabela Rusu, Hassan Jahanandish, Sulaiman Vesal, et al.
NPJ Digital Medicine|June 5, 2026
Enhancing foundation model transfer for prostate cancer detection with patch-level contrastive learningJeong Hoon Lee, Cynthia Xinran Li, Hassan Jahanandish, et al.
Lancet (London, England)|June 11, 2023
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trialCharlotte E Coles, Joanne S Haviland, Anna M Kirby, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
European Urology Oncology|January 29, 2025
ProCUSNet: Prostate Cancer Detection on B-mode Transrectal Ultrasound Using Artificial Intelligence for Targeting During Prostate BiopsiesMirabela Rusu, Hassan Jahanandish, Sulaiman Vesal, et al.
NPJ Digital Medicine|June 5, 2026
Enhancing foundation model transfer for prostate cancer detection with patch-level contrastive learningJeong Hoon Lee, Cynthia Xinran Li, Hassan Jahanandish, et al.
Lancet (London, England)|June 11, 2023
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trialCharlotte E Coles, Joanne S Haviland, Anna M Kirby, et al.
Pageof 4